Literature DB >> 20487201

Cardiovascular effects induced by Cymbopogon winterianus essential oil in rats: involvement of calcium channels and vagal pathway.

Igor Alexandre Côrtes de Menezes1, Italo José Alves Moreira, José Welton Azevedo de Paula, Arie Fitzgerald Blank, Angelo Roberto Antoniolli, Lucindo José Quintans-Júnior, Márcio Roberto Viana Santos.   

Abstract

OBJECTIVES: This study has investigated the cardiovascular effects of the Cymbopogon winterianus essential oil (EOCW) in rats. C. winterianus is a plant used in folk medicine for the treatment of hypertension.
METHODS: For the measurement of haemodynamic and ECG parameters, male Wistar rats under anaesthesia were cannulated in the abdominal aorta and lower vena cava and electrodes were subcutaneously implanted in their paws. For an in-vitro approach, the rats were killed and the superior mesenteric artery was removed and cut into rings (1-2 mm). These rings were then mounted in organ baths containing Tyrode's solution at 37 degrees C and gassed with carbogen. KEY
FINDINGS: In rats, EOCW (1-20 mg/kg, i.v.) induced dose-dependent hypotension and tachycardia. These effects were not affected by L-NAME or indometacin, but were partially reduced after atropine administration. EOCW (20 mg/kg only) also induced bradycardia-associated sinoatrial blockade, junctional rhythm, and first-degree atrioventricular block, which was abolished after atropine administration or vagotomy. In arterial rings, EOCW (0.1-3000 microg/ml) induced relaxation of phenylephrine tonus that was not affected by removal of the endothelium. These relaxations were similar to those observed in rings without endothelium precontracted with KCl 80 mm. EOCW was able to antagonize the CaCl(2) (30-300 mum) induced contractions in depolarizing solution (KCl 60 mm).
CONCLUSIONS: These results demonstrated that EOCW induced hypotension and vasorelaxation. These effects appeared to be mainly mediated by Ca(+2)-channel blocking. Furthermore, the higher dose of EOCW induced transient bradycardia and arrhythmias due to a cardiac muscarinic activation secondary to a vagal discharge.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20487201     DOI: 10.1211/jpp.62.02.0009

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Citronellol, a monoterpene alcohol, reduces nociceptive and inflammatory activities in rodents.

Authors:  Renan G Brito; Adriana G Guimarães; Jullyana S S Quintans; Marcio R V Santos; Damião P De Sousa; Daniel Badaue-Passos; Waldecy de Lucca; Fabíola A Brito; Emiliano O Barreto; Aldeídia P Oliveira; Lucindo J Quintans
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

2.  Chemical composition and vasorelaxant effect induced by the essential oil of Lippia alba (Mill.) N.E. Brown. (Verbenaceae) in rat mesenteric artery.

Authors:  Luana G Maynard; Kátia C Santos; Patrícia S Cunha; André S Barreto; Magna G Peixoto; Fátima Arrigoni-Blank; Arie F Blank; Péricles B Alves; Leonardo R Bonjardin; Márcio R V Santos
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

3.  The contributions of muscarinic receptors and changes in plasma aldosterone levels to the anti-hypertensive effect of Tulbaghia violacea.

Authors:  Ismaila Raji; Pierre Mugabo; Kenechukwu Obikeze
Journal:  BMC Complement Altern Med       Date:  2013-01-11       Impact factor: 3.659

4.  Preparation, Characterization, and Pharmacological Activity of Cymbopogon winterianus Jowitt ex Bor (Poaceae) Leaf Essential Oil of β-Cyclodextrin Inclusion Complexes.

Authors:  Priscila L Santos; Adriano A S Araújo; Jullyana S S Quintans; Makson G B Oliveira; Renan G Brito; Mairim R Serafini; Paula P Menezes; Marcio R V Santos; Pericles B Alves; Waldecy de Lucca Júnior; Arie F Blank; Viviana La Rocca; Reinaldo N Almeida; Lucindo J Quintans-Júnior
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

5.  Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.

Authors:  Hassan N Althurwi; Maged S Abdel-Kader; Khalid M Alharthy; Mohamad Ayman Salkini; Faisal F Albaqami
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.